651 filings
Page 8 of 33
DEFA14A
a2eurlnwpj6 xuk2kkw
15 May 20
Additional proxy soliciting materials
4:06pm
8-K
ae46iw6d4qxxzhbmwww1
12 May 20
Vaxart Announces First Quarter 2020 Financial Results
4:04pm
8-K
tkipq9 gkdaxpb
29 Apr 20
Vaxart Announces Corporate Update for First Quarter 2020
12:00am
DEFA14A
51b0 hy15txhlh
24 Apr 20
Additional proxy soliciting materials
4:02pm
8-K
9oo53ski9 mq
14 Apr 20
Departure of Directors or Certain Officers
4:26pm
8-K
uahug
19 Mar 20
Vaxart Announces Fourth Quarter and Full Year 2019 Financial Results
4:04pm
8-K
19b5c yxi
2 Mar 20
Vaxart Announces $10.0 Million Registered Direct Offering Priced At-the-Market
2:48pm
424B5
v6mqlkvu
2 Mar 20
Prospectus supplement for primary offering
11:44am
SEC STAFF
y01xx6 op2
18 Feb 20
SEC staff action: Order
12:00am
SEC STAFF
lgbb 15knnsscn
6 Feb 20
SEC staff action: Order
12:00am
8-K
osnm7yr6pbt0
2 Jan 20
Cost Associated with Exit or Disposal Activities
4:04pm
8-K
21wbd tvd481
4 Dec 19
Departure of Directors or Certain Officers
4:05pm
8-K
ndsbdbh7a9
21 Nov 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:04pm
8-K
scke6tp7
12 Nov 19
Vaxart Announces Third Quarter 2019 Financial Results and Provides Corporate Update
4:56pm
8-K
wqpis
7 Nov 19
Termination of a Material Definitive Agreement
4:05pm